Sanofi SNY
NASDAQ SNY
$41.96 +0.99 (+2.42%)
At close: Oct 22, 2026 · 4:00 PM EDT

Sanofi (SNY) Free Cash Flow (2009 - 2026)

Updated

Sanofi (SNY) recorded Free Cash Flow of $2.55 billion in the quarter ended Jun 30, 2026, up 64.0% from $1.56 billion a year earlier but down 11.1% from the prior quarter.

Analysis

Sanofi (SNY) Free Cash Flow (2009 - 2026) Analysis & Trends

On a TTM basis, Sanofi's Free Cash Flow came in at $25.2 billion as of Jun 30, 2026, up 12.3% year-over-year; for the year ended Dec 31, 2025, it came in at $16.14 billion, up 21.5% from the prior year.

  • Annual Free Cash Flow has a five-year compound annual growth rate of 21.5% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Free Cash Flow came in at $13.29 billion in the year ended Dec 31, 2024 (-6.7%), $14.24 billion in the year ended Dec 31, 2023 (+60.4%), $8.88 billion in the year ended Dec 31, 2022 (-11.5%) and $10.03 billion in the year ended Dec 31, 2021 (+64.7%).
  • Quarterly Free Cash Flow has ranged from -$495.37 million in the quarter ended Jun 30, 2024 to $11.24 billion in the quarter ended Dec 31, 2025 over the past five years.
  • On a year-over-year basis, Free Cash Flow has increased for four consecutive quarters, with growth averaging 95.0% over the last seven quarters.
  • Peak year-over-year performance for Free Cash Flow in the last five years was growth of 504.9% in the quarter ended Dec 31, 2024, against a decline of 63.1% in the quarter ended Jun 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.87 billion (quarter ended Mar 31, 2026), $11.24 billion (quarter ended Dec 31, 2025) and $8.54 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,142.38 Bn 1,110.97 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 635.12 Bn 554.98 Bn 17.30 Bn 6.36 Bn
3 AbbVie 500.65 Bn 473.76 Bn 12.70 Bn 3.11 Bn
4 Merck 355.26 Bn 309.64 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 300.41 Bn 264.40 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 263.79 Bn 237.48 Bn 12.86 Bn 1.01 Bn
7 Amgen 238.16 Bn 193.56 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 3.43 Bn
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn 302.00 Mn
10 Sanofi 50.52 Bn 17.04 Bn 10.79 Bn 439.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 439.37 Mn
Mar 31, 2026 3.48 Bn
Dec 31, 2025 -2.40 Bn
Sep 30, 2025 11.71 Bn
Jun 30, 2025 -606.73 Mn
Mar 31, 2025 2.81 Bn
Dec 31, 2024 2.25 Bn
Sep 30, 2024 11.58 Bn
Jun 30, 2024 -2.97 Bn
Mar 31, 2024 2.58 Bn
Dec 31, 2023 3.54 Bn
Sep 30, 2023 7.91 Bn
Jun 30, 2023 -609.80 Mn
Mar 31, 2023 3.43 Bn
Jun 30, 2022 -348.93 Mn
Mar 31, 2022 3.57 Bn
Jun 30, 2021 1.25 Bn
Mar 31, 2021 3.25 Bn
Jun 30, 2020 -1.10 Bn
Mar 31, 2020 352.16 Mn
API Access

Sanofi Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=SNY&period=max&api_key=YOUR_API_KEY